| Ytd | -0.29% | |
| 1y | -99.07% |
| Open | Prev Close | 1.70 | Low | 1.70 | High | 1.70 | Mkt Cap | 10.11M | |
| Vol | 0.00 | Avg Vol | 0.00 | EPS | -235.75 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.25 | Short Ratio | 0.09 | Inst. Own | 0.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 01-30 | 50-d Avg | 1.70 | 200-d Avg | 1.70 | 1yr Est | 0.00 |
20% of OST-HER2 treated dogs survived 2-year vs. 1% in control group (p = 0.00995) Over 15,000 dogs